The British pharmaceutical giant GSK has announced the acquisition of the Boston-based biopharmaceutical company IDRx fo...
ADIENNE Pharma & Biotech: A Success Story in Innovation
An Interview with Antonio Francesco Di Naro for the C Suite Feature of Sanità33, by Ludovico Baldessin From pioneering ...
Biotech: Angelini Ventures Leads €20 Million Financing Round for NeumirnaNeumirna Therapeutics: Pioneering RNA-Based Therapies for Neurological Disorders
Neumirna Therapeutics, a Danish biotechnology company specializing in RNA-based therapies for next-generation treatments...
Harnessing Artificial Intelligence to Unlock the Therapeutic Potential of Plant Bioactives
A Revolutionary Approach to Biodiversity Conservation, Medicinal Discovery, and Sustainable Botanical Production “...
Venture Capital in Biotech: Insights from Giovanni Rizzo (Indaco Venture Partners)
In this interview, Giovanni Rizzo, partner at Indaco Venture Partners, shares his insights on the role of venture capita...
BionIT Labs closes a €5.5 million investment round with CDP Venture Capital Sgr, RIF Srl, Sefea Impact Sgr, SIMEST SpA, and Fondazione ENEA Tech e Biomedical
Investment goal: to make the Adam’s Hand bionic prosthesis the premier product in the American prosthetic market and t...